1 | CPH: NSIS.B | Novozymes A/S | 2.86% |
2 | NTLA | Intellia Therapeutics, Inc. | 2.68% |
3 | NTRA | Natera, Inc. | 2.66% |
4 | VERV | Verve Therapeutics, Inc. | 2.28% |
5 | LLY | Eli Lilly and Company | 2.23% |
6 | RGNX | REGENXBIO Inc. | 2.18% |
7 | CRSP | CRISPR Therapeutics AG | 2.15% |
8 | GILD | Gilead Sciences, Inc. | 2.00% |
9 | TWST | Twist Bioscience Corporation | 1.95% |
10 | AGIO | Agios Pharmaceuticals, Inc. | 1.92% |
11 | VCYT | Veracyte, Inc. | 1.91% |
12 | BEAM | Beam Therapeutics Inc. | 1.90% |
13 | UTHR | United Therapeutics Corporation | 1.89% |
14 | VRTX | Vertex Pharmaceuticals Incorporated | 1.83% |
15 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.80% |
16 | MRNA | Moderna, Inc. | 1.76% |
17 | BNTX | BioNTech SE | 1.72% |
18 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.68% |
19 | SWX: NOVN | Novartis AG | 1.61% |
20 | TEM | Tempus AI, Inc. | 1.60% |
21 | AMGN | Amgen Inc. | 1.58% |
22 | GPCR | Structure Therapeutics Inc. | 1.56% |
23 | CTVA | Corteva, Inc. | 1.54% |
24 | SANA | Sana Biotechnology, Inc. | 1.45% |
25 | TXG | 10x Genomics, Inc. | 1.42% |
View WDNA holdings |